Belluscura Share Discussion Threads

[owenski] 22/2/2023 12:50

Results were out on 22 Feb. last year.

[danmart2] 15/2/2023 08:01

Financials don’t look right yet, still looks expensive considering past performance and Chinese manufacturer output is still not proven.

[masurenguy] 10/2/2023 07:53

Exercising the broker option dilutes existing shareholders by 9%. After admission, market cap will be just under £59m at last nights closing price, not circa £492m according to ADVFN.
No position here yet.

[rovi70] 06/2/2023 17:28

Green day.

[rovi70] 02/2/2023 11:58

Breath in.

[dr biotech] 27/1/2023 13:46

News does lift some short term uncertainty, even at 10% its seen as a positive. Ultimately though they have to improve the pace of the sales, and quickly. The conversion price of 50p shows they are not expecting a huge rise in the share price anytime soon, but at least its above todays price.

[johnkidd1] 27/1/2023 13:10

Why a 13% price rise on low volume. Something going on here. Agree prospects for Co look bright but strange share price movements on the back of raising expensive or dilutive debt make me nervous.

[stuffee] 27/1/2023 13:10

Interesting issue of new convertible.

Bell been under cash constraint for few months following transfer of US manufacturing to in house. Has improved quality control but has needed additional cash to build up inventory of required raw materials. This placing should solve cash needs, which in any event appear likely to ease in next few months as Chinese manufacturer starts building up inventory.

With cash constraints solved, improved manufacturing and "best in class" concentrator,
prospects look most encouraging.

New convertible looks attractive, convertible over next 3 years at 50p but with fab 10% yield. Available for subscription by existing shareholders. Pity it's not being listed - might lead to howls from some unable to hold unquoted. I will certainly be grabbing all I can.

Maximum fully diluted market capitalisation still only £70m at 50p. Dilution to existing shareholders minimal; with Dowgate forecasting EBITDA of over £20m in 2025, who cares!

[johnkidd1] 27/1/2023 13:05

Why is this seen as so positive. 10% interest is historically extortionate and if converted to shares quite a dilution. I suppose either this or run out of cash in a month as cashburn quite high. Not really a reason to buy.

[trustedinvestor] 27/1/2023 12:47

Belluscura PLC - Placing of Unsecured Convertible Loan Notes #BELL @Belluscura https://www.voxmarkets.co.uk/rns/announcement/de9b036d-9df1-45a4-9b59-570c72af20d0 #voxmarkets undefinedPositive placing

[owenski] 24/1/2023 14:59

Market Cap. 56m, still loss making and cash looks tight, Seems to be a lot already priced in here and yet to deliver.

[maytrees] 23/1/2023 11:05

Another large trade from yesterday. Why cannot trades be marked up as they occur - fairer all round?

[maytrees] 23/1/2023 10:33

Good morning

Nice to see a small share price gain but why so many trades delayed from yesterday?

[danmart2] 19/1/2023 20:28

I expect another funding raise by the end of 2023 , after that raise will be the time to invest provided they have grown sales and the Chinese manufacturer is able to replicate the product to the same standard

Still lots of risk

[andyman11] 19/1/2023 19:25

For you and me now

[rovi70] 19/1/2023 10:13

The only way is up

[mr macgregor] 16/1/2023 14:57

During FY22 they got through around $21m
Cash had declined to $1.8m by December
You don't need to be a rocket scientist to see what's required.
Whoever says invoice financing and unwinding is going to sort out the mess is living in cloud cuckoo land.

[danmart2] 14/1/2023 19:57

‘Rubbish - you’re a deramper.’

Or just a realist

[pugugly] 14/1/2023 14:20

ADVFN Financials seem wrong.
Coy website -

Number of shares - The number of shares in issue is 123,017,161.

Advfn financals

Belluscura Key Figures
(at previous day's close)
Market Cap. 442.91 m
Shares In Issue 1,121.29 m

Still well over valued (imo)